Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVITAE CORPORATION

(NVTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
17.14(c) 17(c) 15.63(c) 15.76(c) 14.91 Last
2 662 093 3 916 991 4 388 617 4 146 517 1 694 247 Volume
-4.72% -0.82% -8.06% +0.83% -5.39% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 464 M - -
Net income 2021 -471 M - -
Net Debt 2021 438 M - -
P/E ratio 2021 -7,23x
Yield 2021 -
Sales 2022 651 M - -
Net income 2022 -755 M - -
Net Debt 2022 467 M - -
P/E ratio 2022 -4,58x
Yield 2022 -
Capitalization 3 568 M 3 568 M -
EV / Sales 2021 8,64x
EV / Sales 2022 6,20x
Nbr of Employees 2 900
Free-Float 97,4%
More Financials
Company
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other... 
More about the company
Ratings of Invitae Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INVITAE CORPORATION
11/09INVITAE CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
11/09Invitae to Seek Acquisition
CI
11/09Raymond James Adjusts Price Target on Invitae to $36 From $38, Maintains Outperform Rat..
MT
11/09Healthcare Stocks Inching Lower in Premarket Tuesday
MT
11/09Wells Fargo Adjusts Invitae's Price Target to $25 From $35, Keeps Equal-Weight Rating
MT
11/08Third Quarter 2021 Financial Results Conference Call Earnings Presentation
PU
11/08Invitae Posts Wider Q3 Loss as Sales Rise, Lowers 2021 Revenue Guidance; Shares Slump 1..
MT
11/08INVITAE : Q3 Earnings Snapshot
AQ
11/08Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third..
PU
11/08Earnings Flash (NVTA) INVITAE CORPORATION Posts Q3 Loss $-0.81, vs. Street Est of $-0.7..
MT
11/08Earnings Flash (NVTA) INVITAE CORPORATION Posts Q3 Revenue $114.4M, vs. Street Est of $..
MT
11/08Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third..
PR
11/08Invitae Corporation Provides Revenue Guidance for the Year 2021
CI
11/08INVITAE CORP : Results of Operations and Financial Condition (form 8-K)
AQ
11/08Invitae Corporation Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
More news
News in other languages on INVITAE CORPORATION
11/09Les actions du secteur de la santé en baisse dans le pré-marché mardi
11/08Invitae enregistre une perte plus importante au troisième trimestre malgré la hausse de..
11/08Earnings Flash (NVTA) INVITAE CORPORATION affiche un chiffre d'affaires de 114,4 millio..
11/08Invitae Corporation fournit des prévisions de revenus pour l'année 2021
11/08HISTORIQUE DES RÉACTIONS AUX BÉNÉFIC : INVITAE CORP, Indicateur de suivi à 50.0%, Sensible..
More news
Analyst Recommendations on INVITAE CORPORATION
More recommendations
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | NVTA | US46185L1035 | MarketScreener
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 15,76 $
Average target price 35,67 $
Spread / Average Target 126%
EPS Revisions
Managers and Directors
Sean Emerson George Chairman, President & Chief Executive Officer
Roxi Wen Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Layton Wedgeworth Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
INVITAE CORPORATION-62.31%3 568
EXACT SCIENCES CORPORATION-39.19%13 884
GUARDANT HEALTH, INC.-24.22%9 757
BGI GENOMICS CO., LTD.-28.68%5 963
ADAPTIVE BIOTECHNOLOGIES CORPORATION-55.64%3 702
SEEGENE, INC.-31.09%2 920